KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Abbott Laboratories (ABT) Shares Outstanding (Weighted Average) (2016 - 2026)

Abbott Laboratories' Shares Outstanding (Weighted Average) history spans 18 years, with the latest figure at $1.7 billion for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) changed 0.19% to $1.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.7 billion, a 0.19% change, with the full-year FY2025 number at $1.7 billion, changed 0.06% from a year prior.
  • Shares Outstanding (Weighted Average) hit $1.7 billion in Q1 2026 for Abbott Laboratories, roughly flat from $1.7 billion in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for ABT hit a ceiling of $1.8 billion in Q1 2022 and a floor of $1.7 billion in Q1 2025.
  • Historically, Shares Outstanding (Weighted Average) has averaged $1.7 billion across 5 years, with a median of $1.7 billion in 2025.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): decreased 1.24% in 2022 and later rose 0.19% in 2026.
  • Tracing ABT's Shares Outstanding (Weighted Average) over 5 years: stood at $1.8 billion in 2022, then fell by 0.74% to $1.7 billion in 2023, then changed by 0.0% to $1.7 billion in 2024, then increased by 0.06% to $1.7 billion in 2025, then increased by 0.09% to $1.7 billion in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for ABT at $1.7 billion in Q1 2026, $1.7 billion in Q4 2025, and $1.7 billion in Q3 2025.